Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
US-2024091312-A1 · Mar 21, 2024 · US
Jacobs Stefan is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Jacobs Stefan |
| Total patents | 15 |
| First publication | Dec 31, 2015 |
| Latest publication | Mar 21, 2024 |
Publications ranked by popularity score, then publication date.
US-2024091312-A1 · Mar 21, 2024 · US
US-2024059772-A1 · Feb 22, 2024 · US
US-11826402-B2 · Nov 28, 2023 · US
US-11795218-B2 · Oct 24, 2023 · US
US-11541127-B2 · Jan 3, 2023 · US
US-10946069-B2 · Mar 16, 2021 · US
US-2021023177-A1 · Jan 28, 2021 · US
US-2020385460-A1 · Dec 10, 2020 · US
US-10604568-B2 · Mar 31, 2020 · US
US-2019298803-A1 · Oct 3, 2019 · US
Latest publications not already listed above.
US-10314890-B2 · Jun 11, 2019 · US
US-2018000900-A1 · Jan 4, 2018 · US
US-9770487-B2 · Sep 26, 2017 · US
US-2016159901-A1 · Jun 9, 2016 · US
US-2015374789-A1 · Dec 31, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astellas Pharma Inc | 10 |
| Biontech Ag | 5 |
| Ganymed Pharmaceuticals Ag | 5 |
| Tron Translationale Onkologie An Der Univ Der Johannes Gutenberg Univ Mainz | 3 |
| Ganymed Pharmaceuticals Gmbh | 3 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 15 |
| C07K2317/732 | 15 |
| C07K16/28 | 15 |
| A61K2039/505 | 15 |
| A61P43/00 | 14 |